vs
Liberty Broadband Corp(LBRDA)与Tarsus Pharmaceuticals, Inc.(TARS)财务数据对比。点击上方公司名可切换其他公司
Liberty Broadband Corp的季度营收约是Tarsus Pharmaceuticals, Inc.的1.7倍($261.0M vs $151.7M),Liberty Broadband Corp净利率更高(146.7% vs -5.5%,领先152.3%),Tarsus Pharmaceuticals, Inc.同比增速更快(128.4% vs 6.1%),Liberty Broadband Corp自由现金流更多($37.0M vs $13.0M),过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高(134.4% vs 4.3%)
本公司是一家覆盖英、荷、美三地的跨国电信企业,注册地为百慕大,在伦敦、阿姆斯特丹、丹佛设有总部,旗下拥有多家对应司法辖区的运营主体,其中英国主体为公开上市实体,2005年由自由媒体国际业务板块与UnitedGlobalCom合并成立。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司,专注于眼科、皮肤科等专科领域创新疗法的研发和商业化,主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症,核心市场为美国。
LBRDA vs TARS — 直观对比
营收规模更大
LBRDA
是对方的1.7倍
$151.7M
营收增速更快
TARS
高出122.3%
6.1%
净利率更高
LBRDA
高出152.3%
-5.5%
自由现金流更多
LBRDA
多$24.0M
$13.0M
两年增速更快
TARS
近两年复合增速
4.3%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $261.0M | $151.7M |
| 净利润 | $383.0M | $-8.4M |
| 毛利率 | — | — |
| 营业利润率 | 15.7% | -5.3% |
| 净利率 | 146.7% | -5.5% |
| 营收同比 | 6.1% | 128.4% |
| 净利润同比 | 96.4% | 63.8% |
| 每股收益(稀释后) | $2.68 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LBRDA
TARS
| Q4 25 | — | $151.7M | ||
| Q3 25 | — | $118.7M | ||
| Q2 25 | $261.0M | $102.7M | ||
| Q1 25 | $266.0M | $78.3M | ||
| Q4 24 | $263.0M | $66.4M | ||
| Q3 24 | $262.0M | $48.1M | ||
| Q2 24 | $246.0M | $40.8M | ||
| Q1 24 | $245.0M | $27.6M |
净利润
LBRDA
TARS
| Q4 25 | — | $-8.4M | ||
| Q3 25 | — | $-12.6M | ||
| Q2 25 | $383.0M | $-20.3M | ||
| Q1 25 | $268.0M | $-25.1M | ||
| Q4 24 | $291.0M | $-23.1M | ||
| Q3 24 | $142.0M | $-23.4M | ||
| Q2 24 | $195.0M | $-33.3M | ||
| Q1 24 | $241.0M | $-35.7M |
营业利润率
LBRDA
TARS
| Q4 25 | — | -5.3% | ||
| Q3 25 | — | -12.2% | ||
| Q2 25 | 15.7% | -21.6% | ||
| Q1 25 | 16.2% | -33.5% | ||
| Q4 24 | 4.9% | -36.8% | ||
| Q3 24 | 11.5% | -52.3% | ||
| Q2 24 | 8.5% | -81.6% | ||
| Q1 24 | 11.4% | -136.5% |
净利率
LBRDA
TARS
| Q4 25 | — | -5.5% | ||
| Q3 25 | — | -10.6% | ||
| Q2 25 | 146.7% | -19.8% | ||
| Q1 25 | 100.8% | -32.1% | ||
| Q4 24 | 110.6% | -34.8% | ||
| Q3 24 | 54.2% | -48.7% | ||
| Q2 24 | 79.3% | -81.6% | ||
| Q1 24 | 98.4% | -129.4% |
每股收益(稀释后)
LBRDA
TARS
| Q4 25 | — | $-0.17 | ||
| Q3 25 | — | $-0.30 | ||
| Q2 25 | $2.68 | $-0.48 | ||
| Q1 25 | $1.87 | $-0.64 | ||
| Q4 24 | $2.04 | $-0.57 | ||
| Q3 24 | $0.99 | $-0.61 | ||
| Q2 24 | $1.36 | $-0.88 | ||
| Q1 24 | $1.69 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $180.0M | $417.3M |
| 总债务越低越好 | $3.1B | $72.4M |
| 股东权益账面价值 | $10.4B | $343.4M |
| 总资产 | $16.6B | $562.2M |
| 负债/权益比越低杠杆越低 | 0.30× | 0.21× |
8季度趋势,按日历期对齐
现金及短期投资
LBRDA
TARS
| Q4 25 | — | $417.3M | ||
| Q3 25 | — | $401.8M | ||
| Q2 25 | $180.0M | $381.1M | ||
| Q1 25 | $226.0M | $407.9M | ||
| Q4 24 | $163.0M | $291.4M | ||
| Q3 24 | $168.0M | $317.0M | ||
| Q2 24 | $73.0M | $323.6M | ||
| Q1 24 | $108.0M | $298.5M |
总债务
LBRDA
TARS
| Q4 25 | — | $72.4M | ||
| Q3 25 | — | $72.3M | ||
| Q2 25 | $3.1B | $72.1M | ||
| Q1 25 | $3.8B | $72.0M | ||
| Q4 24 | $3.8B | $71.8M | ||
| Q3 24 | $3.7B | $71.7M | ||
| Q2 24 | $3.6B | $71.6M | ||
| Q1 24 | $3.6B | $29.9M |
股东权益
LBRDA
TARS
| Q4 25 | — | $343.4M | ||
| Q3 25 | — | $335.1M | ||
| Q2 25 | $10.4B | $332.6M | ||
| Q1 25 | $10.1B | $342.5M | ||
| Q4 24 | $9.8B | $224.5M | ||
| Q3 24 | $9.5B | $237.5M | ||
| Q2 24 | $9.3B | $252.2M | ||
| Q1 24 | $9.1B | $275.2M |
总资产
LBRDA
TARS
| Q4 25 | — | $562.2M | ||
| Q3 25 | — | $534.6M | ||
| Q2 25 | $16.6B | $495.0M | ||
| Q1 25 | $17.0B | $500.8M | ||
| Q4 24 | $16.7B | $377.0M | ||
| Q3 24 | $16.3B | $376.3M | ||
| Q2 24 | $16.0B | $376.8M | ||
| Q1 24 | $15.7B | $349.3M |
负债/权益比
LBRDA
TARS
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | 0.30× | 0.22× | ||
| Q1 25 | 0.38× | 0.21× | ||
| Q4 24 | 0.38× | 0.32× | ||
| Q3 24 | 0.39× | 0.30× | ||
| Q2 24 | 0.39× | 0.28× | ||
| Q1 24 | 0.40× | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $91.0M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $37.0M | $13.0M |
| 自由现金流率自由现金流/营收 | 14.2% | 8.6% |
| 资本支出强度资本支出/营收 | 20.7% | 4.2% |
| 现金转化率经营现金流/净利润 | 0.24× | — |
| 过去12个月自由现金流最近4个季度 | $-49.0M | $-22.3M |
8季度趋势,按日历期对齐
经营现金流
LBRDA
TARS
| Q4 25 | — | $19.3M | ||
| Q3 25 | — | $18.3M | ||
| Q2 25 | $91.0M | $-29.4M | ||
| Q1 25 | $78.0M | $-20.7M | ||
| Q4 24 | $1.0M | $-22.2M | ||
| Q3 24 | $24.0M | $-8.7M | ||
| Q2 24 | $27.0M | $-14.4M | ||
| Q1 24 | $52.0M | $-37.8M |
自由现金流
LBRDA
TARS
| Q4 25 | — | $13.0M | ||
| Q3 25 | — | $16.3M | ||
| Q2 25 | $37.0M | $-30.4M | ||
| Q1 25 | $13.0M | $-21.2M | ||
| Q4 24 | $-63.0M | $-22.3M | ||
| Q3 24 | $-36.0M | $-8.9M | ||
| Q2 24 | $-35.0M | $-15.4M | ||
| Q1 24 | $-9.0M | $-38.0M |
自由现金流率
LBRDA
TARS
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | 14.2% | -29.6% | ||
| Q1 25 | 4.9% | -27.1% | ||
| Q4 24 | -24.0% | -33.5% | ||
| Q3 24 | -13.7% | -18.6% | ||
| Q2 24 | -14.2% | -37.8% | ||
| Q1 24 | -3.7% | -137.5% |
资本支出强度
LBRDA
TARS
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | 20.7% | 1.0% | ||
| Q1 25 | 24.4% | 0.8% | ||
| Q4 24 | 24.3% | 0.1% | ||
| Q3 24 | 22.9% | 0.6% | ||
| Q2 24 | 25.2% | 2.5% | ||
| Q1 24 | 24.9% | 0.6% |
现金转化率
LBRDA
TARS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.24× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.17× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.22× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图